FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1821-1827 June 24, 1993 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

More than 300 million people cross international boundaries each year¹. Diarrhea is by far the most common medical problem among people traveling to the tropical and semitropical areas of Latin America; parts of the Caribbean, such as Haiti and the Dominican Republic; southern Asia; and North, East, and West Africa². It affects 20 to 50 percent of such travelers³. The threat of diarrhea and the illness itself represent great economic costs to the traveling public and the host country. The loss of income from tourism and the failure of business ventures caused by the threat of illness . . . [Full Text of this Article]

Cause and Sources of Traveler's Diarrhea

Clinical Features of Traveler's Diarrhea

Prophylaxis

The Argument against Prophylaxis

The Decision to Use Prophylaxis

Treatment of Traveler's Diarrhea

Counseling Travelers to High-Risk Areas

Selecting Food and Beverages

Infants, Children, and Pregnant Women

Other Considerations

Future Developments

Source Information

From the Center for Infectious Diseases, University of Texas Medical School and School of Public Health, Houston.

Address reprint requests to Dr. DuPont at 6431 Fannin, 1.729 JFB, Houston, TX 77030.

References

Related Letters:

Prevention and Treatment of Traveler's Diarrhea
Cesarman G., Cesarman E., Lagos G., Osterholm M. T., Hedberg C. W., MacDonald K. L., Meyers A., DuPont H. L., Ericsson C. D.
Extract | Full Text  
N Engl J Med 1993; 329:1584-1585, Nov 18, 1993. Correspondence

This article has been cited by other articles:

• Huang, D. B., Mohamed, J. A., Nataro, J. P., DuPont, H. L., Jiang, Z.-D., Okhuysen, P. C. (2007). Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries. J Med Microbiol 56: 1386-1392 [Abstract] [Full Text]  
• Huang, D. B., Mohanty, A., DuPont, H. L., Okhuysen, P. C., Chiang, T. (2006). A review of an emerging enteric pathogen: enteroaggregative Escherichia coli.. J Med Microbiol 55: 1303-1311 [Abstract] [Full Text]  
• Diemert, D. J. (2006). Prevention and Self-Treatment of Traveler's Diarrhea. Clin. Microbiol. Rev. 19: 583-594 [Abstract] [Full Text]  
• TAYLOR, D. N., BOURGEOIS, A. L., ERICSSON, C. D., STEFFEN, R., JIANG, Z.-D., HALPERN, J., HAAKE, R., DUPONT, H. L., THE RIFAXIMIN STUDY GROUP, (2006). A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF RIFAXIMIN COMPARED WITH PLACEBO AND WITH CIPROFLOXACIN IN THE TREATMENT OF TRAVELERS' DIARRHEA. Am J Trop Med Hyg 74: 1060-1066 [Abstract] [Full Text]  
• Fleck, S., Jager, H., Zeeb, H. (2006). Travel and health status: a survey follow-up study. Eur J Public Health 16: 96-100 [Abstract] [Full Text]  
• Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., Cetron, M. S., the GeoSentinel Surveillance Network, (2006). Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers. NEJM 354: 119-130 [Abstract] [Full Text]  
• Ko, G., Garcia, C., Jiang, Z.-D., Okhuysen, P. C., Belkind-Gerson, J., Glass, R. I., DuPont, H. L. (2005). Noroviruses as a Cause of Traveler's Diarrhea among Students from the United States Visiting Mexico. J. Clin. Microbiol. 43: 6126-6129 [Abstract] [Full Text]  
• DuPont, H. L., Jiang, Z.-D., Okhuysen, P. C., Ericsson, C. D., de la Cabada, F. J., Ke, S., DuPont, M. W., Martinez-Sandoval, F. (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea. ANN INTERN MED 142: 805-812 [Abstract] [Full Text]  
• Gorbach, S. L. (2005). How To Hit the Runs for Fifty Million Travelers at Risk. ANN INTERN MED 142: 861-862 [Full Text]  
• Huang, D. B., Musher, D., Musher, B. L. (2005). Contagious Acute Gastrointestinal Infections. NEJM 352: 1267-1268 [Full Text]  
• Chapin, A. R., Carpenter, C. M., Dudley, W. C., Gibson, L. C., Pratdesaba, R., Torres, O., Sanchez, D., Belkind-Gerson, J., Nyquist, I., Karnell, A., Gustafsson, B., Halpern, J. L., Bourgeois, A. L., Schwab, K. J. (2005). Prevalence of Norovirus among Visitors from the United States to Mexico and Guatemala Who Experience Traveler's Diarrhea. J. Clin. Microbiol. 43: 1112-1117 [Abstract] [Full Text]  
• Pakyz, A. L (2005). Rifaximin: A New Treatment for Travelers' Diarrhea. The Annals of Pharmacotherapy 39: 284-289 [Abstract] [Full Text]  
• Casburn-Jones, A C, Farthing, M J G (2004). Management of infectious diarrhoea. Gut 53: 296-305 [Full Text]  
• Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., Joshi, N. (2003). Trimethoprim-Sulfamethoxazole Revisited. Arch Intern Med 163: 402-410 [Abstract] [Full Text]  
• Van Looveren, M., Daube, G., De Zutter, L., Dumont, J.-M., Lammens, C., Wijdooghe, M., Vandamme, P., Jouret, M., Cornelis, M., Goossens, H. (2001). Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother 48: 235-240 [Abstract] [Full Text]  
• Marteau, P. R, Vrese, M. d., Cellier, C. J, Schrezenmeir, J. (2001). Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73: 430S-436 [Abstract] [Full Text]  
• Gomi, H., Jiang, Z.-D., Adachi, J. A., Ashley, D., Lowe, B., Verenkar, M. P., Steffen, R., DuPont, H. L. (2001). In Vitro Antimicrobial Susceptibility Testing of Bacterial Enteropathogens Causing Traveler's Diarrhea in Four Geographic Regions. Antimicrob. Agents Chemother. 45: 212-216 [Abstract] [Full Text]  
• Jiang, Z.-D., Ke, S., Palazzini, E., Riopel, L., Dupont, H. (2000). In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration. Antimicrob. Agents Chemother. 44: 2205-2206 [Abstract] [Full Text]  
• Ryan, E. T., Kain, K. C. (2000). Health Advice and Immunizations for Travelers. NEJM 342: 1716-1725 [Full Text]  
• Vila, J., Vargas, M., Ruiz, J., Corachan, M., Jimenez de Anta, M. T., Gascon, J. (2000). Quinolone Resistance in Enterotoxigenic Escherichia coli Causing Diarrhea in Travelers to India in Comparison with Other Geographical Areas. Antimicrob. Agents Chemother. 44: 1731-1733 [Abstract] [Full Text]  
• de Roos, N. M, Katan, M. B (2000). Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 19981. Am. J. Clin. Nutr. 71: 405-411 [Abstract] [Full Text]  
• Hasegawa, M., Hidaka, Y., Matsumoto, Y., Sanni, T., Shimonishi, Y. (1999). Determination of the Binding Site on the Extracellular Domain of Guanylyl Cyclase C to Heat-stable Enterotoxin. J. Biol. Chem. 274: 31713-31718 [Abstract] [Full Text]  
• Menzies, I S, Zuckerman, M J, Nukajam, W S, Somasundaram, S G, Murphy, B, Jenkins, A P, Crane, R S, Gregory, G G (1999). Geography of intestinal permeability and absorption. Gut 44: 483-489 [Abstract] [Full Text]  
• Steffen, R., Collard, F., Tornieporth, N., Campbell-Forrester, S., Ashley, D., Thompson, S., Mathewson, J. J., Maes, E., Stephenson, B., DuPont, H. L., von Sonnenburg, F. (1999). Epidemiology, Etiology, and Impact of Traveler's Diarrhea in Jamaica. JAMA 281: 811-817 [Abstract] [Full Text]  
• Goossens, H., Sprenger, M. J W (1998). Community acquired infections and bacterial resistance. BMJ 317: 654-657 [Full Text]  
• Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201 [Abstract] [Full Text]  
• Katelaris, P. H., Salam, I., Farthing, M. J.G. (1995). Lactobacilli to Prevent Traveler's Diarrhea?. NEJM 333: 1360-1361 [Full Text]  
• Cesarman, G., Cesarman, E., Lagos, G., Osterholm, M. T., Hedberg, C. W., MacDonald, K. L., Meyers, A., DuPont, H. L., Ericsson, C. D. (1993). Prevention and Treatment of Traveler's Diarrhea. NEJM 329: 1584-1585 [Full Text]